Merck
@Merck
Today, we shared positive Phase 3 topline results in certain patients with advanced or recurrent #EndometrialCancer. These findings mark an important step forward as we work to advance new treatment options for these patients. Learn more: go.merck.com/~ja6
0:06 2 10